Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.8%

5 terminated/withdrawn out of 64 trials

Success Rate

84.4%

-2.1% vs industry average

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

67%

18 of 27 completed trials have results

Key Signals

14 recruiting18 with results

Enrollment Performance

Analytics

N/A
52(92.9%)
Phase 2
3(5.4%)
Phase 3
1(1.8%)
56Total
N/A(52)
Phase 2(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (64)

Showing 20 of 64 trials
NCT07102160Recruiting

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Role: collaborator

NCT03908177Not ApplicableCompleted

Comparison of Clinical Performance and Safety of Zirconia vs. Titanium Implants: a Multi-national RCT.

Role: collaborator

NCT03983512Not ApplicableActive Not Recruiting

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Role: collaborator

NCT06424262Not ApplicableActive Not Recruiting

Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622)

Role: collaborator

NCT07370493Enrolling By Invitation

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

Role: collaborator

NCT06338670Not ApplicableCompleted

Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users

Role: collaborator

NCT05552118Not ApplicableActive Not Recruiting

Speech Performance and Clinic Efficiency With Remote Care Compared With Standard of Care in Adults With a Cochlear Implant in the First 12 Months Post-activation

Role: collaborator

NCT06358508Not ApplicableCompleted

Sapphire 3 CTO Study

Role: collaborator

NCT06959121Not ApplicableRecruiting

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

Role: collaborator

NCT06355063Not ApplicableRecruiting

CellFX® nsPFA™ Cardiac Surgery System to Treat Atrial Fibrillation

Role: collaborator

NCT07156461Not ApplicableCompleted

Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients

Role: collaborator

NCT06358157Not ApplicableActive Not Recruiting

The Ladera Large Bore Closure Feasibility Study

Role: collaborator

NCT06298396Not ApplicableCompleted

Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implant Recipients

Role: collaborator

NCT06689839Not ApplicableRecruiting

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Role: collaborator

NCT06556654Not ApplicableRecruiting

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

Role: collaborator

NCT04807842Not ApplicableRecruiting

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

Role: collaborator

NCT04796350Not ApplicableRecruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Role: collaborator

NCT05619575Not ApplicableCompleted

Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients

Role: collaborator

NCT07130994Not ApplicableNot Yet Recruiting

Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

Role: collaborator

NCT05481931Active Not Recruiting

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Role: collaborator